Chief Executive Officer
CurrentAzurity Pharmaceuticals is a privately held pharmaceutical company providing treatments for rare and orphan conditions and dose-from innovations of established medicines for patients who have unmet needs. A portfolio company of QHP Capital. We are deeply committed to our purpose of Serving Overlooked Patients. Azurity's portfolio includes 23 branded FDA-approved products in seven therapeutic areas.